Big Pharmas Vying for Product Specific Deals in Global RNAi Industry
With an anticipated change in the patents and licenses scenario in the pharmaceutical industry, it is expected that more firms would explore RNAi technology to offer RNAi based products, says RNCOS.
View full press release